Quiero saber acerca de...

Federal Register / Vol. 86, No. 147 / Wednesday, August 4, 2021 / Notices Place: Fogarty International Center, National Institutes of Health, 31 Center Drive, Bethesda, MD 20892 Virtual Meeting.
Open: September 10, 2021, 12:00 p.m. to 3:00 p.m.
Agenda: Update and discussion of current and planned Fogarty International Center activities.
Place: Fogarty International Center, National Institutes of Health, 31 Center Drive, Bethesda, MD 20892 Virtual Meeting.
Meeting Access: https www.fic.nih.gov/
About/Advisory/Pages/default.aspx.
Contact Person: Kristen Weymouth, Executive Secretary, Fogarty International Center, National Institutes of Health, 31
Center Drive, Room B2C02, Bethesda, MD
208927952, 3014961415, kristen.weymouth@nih.gov.
Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person.
Information is also available on the Institutes/Centers home page: http
www.fic.nih.gov/About/Advisory/Pages/
default.aspx, where an agenda and any additional information for the meeting will be posted when available.
Catalogue of Federal Domestic Assistance Program Nos. 93.106, Minority International Research Training Grant in the Biomedical and Behavioral Sciences; 93.154, Special International Postdoctoral Research Program in Acquired Immunodeficiency Syndrome;
93.168, International Cooperative Biodiversity Groups Program; 93.934, Fogarty International Research Collaboration Award;
93.989, Senior International Fellowship Awards Program, National Institutes of Health, HHS
Dated: July 30, 2021.
Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy.
FR Doc. 202116607 Filed 8321; 8:45 am BILLING CODE 414001P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
lotter on DSK11XQN23PROD with NOTICES1

Center for Scientific Review; Notice of Closed Meeting Pursuant to section 10d of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552bc4 and 552bc6, Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning
VerDate Sep<11>2014

16:45 Aug 03, 2021

Jkt 253001

individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis Panel; Fellowship:
Cardiovascular and Respiratory Sciences Overflow.
Date: August 27, 2021.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 Virtual Meeting.
Contact Person: Kimm Hamann, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4118A, MSC 7814, Bethesda, MD 20892, 301 435
5575, hamannkj@csr.nih.gov.
Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333, 93.337, 93.39393.396, 93.83793.844, 93.84693.878, 93.892, 93.893, National Institutes of Health, HHS
Dated: July 30, 2021.
Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy.
FR Doc. 202116609 Filed 8321; 8:45 am BILLING CODE 414001P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health National Institute on Drug Abuse;
Notice of Meeting Pursuant to section 10d of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Advisory Council on Drug Abuse.
The meeting will be held as a virtual meeting and is open to the public, as indicated below. Individuals who plan to view the virtual meeting and need special assistance or other reasonable accommodations to view the meeting, should notify the Contact Person listed below in advance of the meeting. The open session will be videocast and can be accessed from the NIH Videocasting and Podcasting website http
videocast.nih.gov/.
A portion of this will be closed to the public in accordance with the provisions set forth in sections 552bc4 and 552bc6, Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which
PO 00000

Frm 00047

Fmt 4703

Sfmt 4703

41983

would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Council on Drug Abuse.
Date: September 15, 2021.
Closed: 11:00 a.m. to 12:15 p.m.
Agenda: To review and evaluate grant applications.
Open: 12:45 p.m. to 4:30 p.m.
Agenda: Presentations and other business of the Council.
Place: National Institutes of Health, National Institute on Drug Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892
Virtual Meeting.
Contact Person: Susan R.B. Weiss, Ph.D., Director, Division of Extramural Research, Office of the Director, National Institute on Drug Abuse, NIH, Three White Flint North, RM 09D08, 11601 Landsdown Street, Bethesda, MD 20852, 3014436480, sweiss@
nida.nih.gov.
Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person.
Information is also available on the Institutes/Centers home page:
www.drugabuse.gov/NACDA/
NACDAHome.html, where an agenda and any additional information for the meeting will be posted when available.
Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug Abuse Scientist Development Award for Clinicians, Scientist Development Awards, and Research Scientist Awards; 93.278, Drug Abuse National Research Service Awards for Research Training; 93.279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS
Dated: July 29, 2021.
Tyeshia M. Roberson-Curtis, Program Analyst, Office of Federal Advisory Committee Policy.
FR Doc. 202116577 Filed 8321; 8:45 am BILLING CODE 414001P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health National Heart, Lung, and Blood Institute; Notice of Meeting Pursuant to section 10d of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Heart, Lung, and Blood Advisory Council.
The meeting will be open to the public as indicated below and held as a virtual meeting. Individuals who plan to view the virtual meeting and need special assistance or other reasonable accommodations to view the meeting, should notify the Contact Person listed below in advance of the meeting.

E:FRFM04AUN1.SGM

04AUN1